Clinical Report: Role of SII and SIRI in Mortality Risk Assessment

Overview

The study identifies the systemic immune-inflammation index (SII) and systemic inflammation response index (SIRI) as independent risk factors for mortality in a community-based cohort. Both indices are associated with increased hazards of all-cause and cause-specific mortality.

Background

Understanding the role of systemic inflammation in mortality is crucial, particularly as chronic low-grade inflammation is increasingly recognized as a hallmark of aging. The SII and SIRI, derived from complete blood count parameters, offer a means to assess inflammation and its implications for health outcomes.

Data Highlights

No numerical data was provided in the source material.

Key Findings

• The SII and SIRI are independent risk factors for overall mortality.
• Both indices are significantly associated with cardiovascular and respiratory mortality.
• In acute inflammatory states, the SII reflects hyperinflammation and hematologic consumption.
• The SII is influenced by chronic metabolic conditions and subclinical infections.
• Current evidence gaps necessitate cautious interpretation and validation of these indices.

Clinical Implications

Clinicians should be aware of the limitations and potential confounding factors that may affect the accuracy of SII and SIRI in acute care environments.

Conclusion

Further validation of the SII and SIRI is essential before clinical implementation can be justified.

Related Resources & Content

1. Ke et al., Front. Med, 2026 -- Impact of systemic immune-inflammation index and systemic inflammation response index on all-cause and cause-specific mortality
2. Frontiers in Medicine — Associations of the systemic immune-inflammation index and systemic inflammatory response index with chronic obstructive pulmonary disease: a systematic review and meta-analysis
3. The Journal of Clinical Endocrinology & Metabolism — Age-Related Variations in the Relationship Between Systemic Inflammatory Response and Metabolic Syndrome
4. Frontiers in Cardiovascular Medicine — Correction: Association between systemic immune-inflammation index(SII) and all-cause and cardiovascular mortality in heart failure patients: a single-center retrospective analysis
5. Frontiers in Oncology — Association of systemic immune-inflammation index with all-cause mortality in lung cancer patients undergoing radiotherapy: a retrospective cohort study
6. Systemic immune-inflammation index (SII) and the risk of all-cause, cardiovascular, and cardio-cerebrovascular mortality in the general population - PMC
7. Frontiers | Impact of systemic immune-inflammation index and systemic inflammation response index on all-cause and cause-specific mortality: a community-based cohort study
8. PREVENT Equations Quickstart Guide